Japanese Pharmaceuticals & Biotech Most Popular Stocks

Chugai Pharmaceutical

Market Cap: JP¥12.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Takeda Pharmaceutical

Market Cap: JP¥8.5t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.

Otsuka Holdings

Market Cap: JP¥5.9t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Daiichi Sankyo Company

Market Cap: JP¥4.9t

Manufactures and sells pharmaceutical products in Japan and internationally.

Astellas Pharma

Market Cap: JP¥3.8t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

Shionogi

Market Cap: JP¥2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

Eisai

Market Cap: JP¥1.2t

Engages in the research, development, manufacture, and sale of pharmaceuticals in Japan.

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Santen Pharmaceutical

Market Cap: JP¥686.8b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Sumitomo Pharma

Market Cap: JP¥628.0b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Tsumura

Market Cap: JP¥284.8b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Nippon Shinyaku

Market Cap: JP¥275.1b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Towa Pharmaceutical

Market Cap: JP¥198.1b

Manufactures and sale ethical drugs in Japan.

Sawai Group Holdings

Market Cap: JP¥193.2b

Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.

GNI Group

Market Cap: JP¥171.4b

Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.

Kissei Pharmaceutical

Market Cap: JP¥170.0b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Kaken Pharmaceutical

Market Cap: JP¥145.4b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

PeptiDream

Market Cap: JP¥130.9b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Mochida Pharmaceutical

Market Cap: JP¥111.1b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

Zeria Pharmaceutical

Market Cap: JP¥91.7b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Nxera Pharma

Market Cap: JP¥85.1b

Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.

SanBio

Market Cap: JP¥77.2b

Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.

Oncolys BioPharma

Market Cap: JP¥75.4b

Engages in the research, development, manufacturing, sale, and import of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the United States, and Asia.

KYORIN Pharmaceutical

Market Cap: JP¥67.7b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥64.1b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

JCR Pharmaceuticals

Market Cap: JP¥58.2b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥53.1b

A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

Fuji Pharma

Market Cap: JP¥49.5b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

3-D Matrix

Market Cap: JP¥44.9b

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally.

Cuorips

Market Cap: JP¥39.7b

Engages in the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets.

Seikagaku

Market Cap: JP¥39.6b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.

Heartseed

Market Cap: JP¥36.8b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

Healios K.K

Market Cap: JP¥35.2b

Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

Daito PharmaceuticalLtd

Market Cap: JP¥34.5b

Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.

Japan Tissue Engineering

Market Cap: JP¥26.2b

Engages in the regenerative medicine business in Japan.